
### [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320)
**Label:** rare hereditary thrombophilia

**Subclasses:** [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein c deficiency, autosomal recessive), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein c deficiency), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein c deficiency, autosomal dominant), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (protein S acquired deficiency), 

**Corr. equiv. classes:** [OMIM:176860](http://purl.obolibrary.org/obo/OMIM_176860), [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [OMIM:613116](http://purl.obolibrary.org/obo/OMIM_613116), [Orphanet:26349](http://www.orpha.net/ORDO/Orphanet_26349), [OMIM:612304](http://purl.obolibrary.org/obo/OMIM_612304), [OMIM:613118](http://purl.obolibrary.org/obo/OMIM_613118), [Orphanet:745](http://www.orpha.net/ORDO/Orphanet_745), [Orphanet:82](http://www.orpha.net/ORDO/Orphanet_82), [Orphanet:217467](http://www.orpha.net/ORDO/Orphanet_217467), [Orphanet:743](http://www.orpha.net/ORDO/Orphanet_743), 

**Class expressions from DL-Learner:**

- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) 68.18%
- [HP:0002204](http://purl.obolibrary.org/obo/HP_0002204) (Pulmonary embolism) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 68.18%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 68.18%
- [HP:0001928](http://purl.obolibrary.org/obo/HP_0001928) (Abnormality of coagulation) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 68.18%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 68.18%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 68.18%


